Analysis

CVS Health reported a drug price growth of just 0.2 percent last year, thanks to strategies that promoted low- or no-cost drugs for consumers.

The number is an eightfold increase since 2004—and more than half of that amount went to treat employees' children.

The decline is a victory for Obamacare supporters, who faced an uphill battle during and leading up to this year's enrollment period.

Communication barriers are leading to a delay or failure to complete projects, low morale , missed performance goals (25 percent) and even lost sales.

The HHS inspector general estimated that California spent $738.2 million on 366,078 expansion beneficiaries who were ineligible.

One quirky provision in an SEC proposal could expose ETF investors to a new risk.